Overall, these findings highlight ACA as a potent apoptosis-inducing agent in lymphoma cells, acting primarily through mitochondrial pathways and c-Myc suppression, whereas galangin offers a safer alternative with cytostatic and immune-modulating properties. Here, MYC is linked to lymphoma.